Vital Therapies Joins the Russell 3000 Index®
June 25 2018 - 8:00AM
Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company
developing ELAD®, a cell-based therapy targeting the treatment of
acute forms of liver failure, announced it has been added as a
member of the broad-market Russell 3000® Index, effective after the
U.S. market opens today, as part of the 2018 Russell indexes
reconstitution.
The annual Russell U.S. Indexes reconstitution
captures the 4,000 largest U.S. stocks as of May 11, ranking them
by total market capitalization. Membership in the Russell 3000®
Index, which remains in place for one year, means automatic
inclusion in the large-cap Russell 1000® Index or small-cap Russell
2000® Index as well as the appropriate growth and value style
indexes. FTSE Russell determines membership for its Russell U.S.
Indexes primarily by objective, market-capitalization rankings and
style attributes.
Russell U.S. Indexes are widely used by
investment managers and institutional investors as the basis for
index funds and as benchmarks for active investment strategies.
Approximately $9 trillion in assets are benchmarked against Russell
U.S. Indexes. Russell U.S. Indexes are part of FTSE Russell, a
leading global index provider.
For more information on the Russell 3000® Index
and the Russell U.S. Indexes reconstitution, go to the “Russell
Reconstitution” section on the FTSE Russell website.
About Vital Therapies,
Inc.Vital Therapies, Inc. is a biotherapeutic company
developing a cell-based therapy targeting the treatment of acute
forms of liver failure. The Company’s ELAD System is an
extracorporeal human allogeneic cellular liver therapy with a fully
enrolled phase 3 clinical trial that is anticipated to report
topline results in September 2018. Vital Therapies, Inc. is based
in San Diego, California. Vital Therapies® and ELAD® are
trademarks of Vital Therapies, Inc.
Contact:Vital Therapies, Inc. Al KildaniVice President,
Investor Relations and Business Development
858-673-6840akildani@vitaltherapies.com
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Apr 2023 to Apr 2024